
indian hotal is also looking good on chart we have short term target of indian hotal 170 one must have delivery of it and one can also make postion in future and option

CIPLA is also doing well in the phrma industery one must have delivery of cipla it will croos 350 this year many funds and traders are loking on this counter and many have already invested so the next quater result of cipla will also beat the market expectaion his medicine tamiflu 75mg is rocking the market,

Spot Nifty has to stay above 4089 to maintain strength.Sustained trade above 4100signals further upside. Major Support is at 407O & 4020.Resistance is at 4125 & 4174.Intra Day Entry Setup:Buy: @ or near 4090 If NF go below this price and move up Sl 4076 Target –4130, 4148.If opens Gap up & sustains above Buy: @ or near 4149 If NF moves above this priceSl 4124 Target – 4174.Sell: @ or near 4147 If NF go above this and move downSl 4174 Target –4119, 4091.If opens Gap down & sustains belowSell: @ or near 4076 If NF moves down below this priceSl 4110 Target – 4054, 4029.Swing Trade Entry Setup:Buy: @ or near 4076 near If NF go below this price and move upSl 4027 Target –4028, 4160.Sell: @ or near 4147 If NF moves down below this priceSl 4185 Target 4077, 4029.

Nucleus Software Exports Ltd is looking at Europe and Japan to expand its business next year. The company provides its technology in the area of retail banking and cash management in geographies such as Asia pacific, West Asia, Europe and Africa."Currently, less than 10 per cent of our revenues come from Europe. But we expect it to get doubled over the coming year from this region. While, traditionally significant portion of our revenues come from South and South East Asia, West Asia and Europe, we are now expecting our business to grow from Europe and Japan. General Motors has been our major client in Europe. We are in talks with major auto finance companies in Europe," said Mr Niraj Vedwa, Head of Global Sales and Marketing'.Mr Vedwa said that Nucleus had recently signed up with two private banks and one nationalised bank, about four major banks in Africa, two in the UAE, two more in Indonesia in the quarter — though, he declined to divulge the names of the new banks. However, he said that revenues accrued from these would be declared only during their quarter ending January 2007.Nucleus had announced about $8.5 million worth of contract and expects the growth to be higher for this quarter based on new contracts that have been signed. Currently, 80 per cent of the company's revenues come from retail banking and about 20 per cent from cash management software.
IBM-Nucleus On Demand Solution Series -2006" Breakfast meet in Philippines a grand success
"IBM-Nucleus On Demand Solution Series - 2006", b reakfast meet in Philippines earlier this year, in collaboration with our technology partner IBM, was a grand success. A total of 40 bankers across functional domain attended the seminar. This was a whopping 85 % turnout even though it was raining heavily! The discussion was on “Future Cash Management Trends” and cash management domain got a very positive response generating a whole lot of queries during the Q & A session that we finally had to request to be emailed. The presentations were powerful & informative driving the event.
As one of our clients wrote “remarkable and insightful presentation. I always have this general impression that there's nothing new or innovative services left to offer our clients. My outlook changed when I heard a number of very innovative offerings presented yesterday.”
As per IBM, it was an exceptional turnout for a break fast event.
ONE CAN BUY WITH ATRGET OF 1200 IN 3 MONTHS

Krebs Biochem- Rs 99Ranbaxy has picked up 14.8% stake in Krebs Biochem at Rs 85/per share. The company has manufacturing facility for statins which also has got US FDA. The move is likely to improve the plant utilization. The company is expected to see turn around with this fund infusion as it currently carries high level of debt. The pharma API business is currently making profit while its sugar business is showing loss. We recommend investors Buy the stock with medium term perspective. ITC-Rs170ITC announced its plans to open 140 stores under Choupal Fresh in 54 towns. The focus is to establish the chain for distributing Fruits and Vegetables. The format consist of both whole sale and retail format. The Agri business which currently contributes 14% of the revenues is likely to see high share in the revenues in coming years. At current market price, the stock trades at We recommend investors to Buy the stock 23.7x and 21.7x FY07E and FY08E earnings. We recommend investors to Buy the stock with price target of Rs 213 over 12 months.*HOT NEWS*ICSA -Rs.1099.25ICSA is divesting 14% of its stake to Citigroup venture Capital for $30mn. Goldman Sachs is also investing $22mn through FCCBs. As per understanding FCCBs will be converting over 5 years at a premium of 40% as permarket rate prevailing at the time of conversion.

Present Price – Rs.437 Projected Price – Rs.490This company is a dominant leader in Industrial Batteries and is emerging as a fast growing brand in the Automotive Batteries segment. It's brand is the second largest selling battery brand in the country today. It sources this technology from its partner, Johnson Controls Inc., which holds a 26% equity stake in the company. It enjoys a market share of more than 50% in the domestic industrial battery market. Over the years, It has developed a strong base in the industrial battery segment wherein it has railways and major telecom companies as its clients. It also enjoys a strong presence in other power-control applications in process industries, oil and power sectors. On the technical front, the stock has broken out of a bullish pattern after a long consolidation. Buying is advised at current levels and at all declines. Long term holders can expect higher targets.

Company Snapshot - Educomp Solutions Ltd.
Educomp computer is loking good at the chats its now atrading stock the company is doing well in this quater also so one can buy educomp with a atrg of 1500 and one thing must keep in mind its atrding stock exit when it breakes the level of 946
state bank of india
Indian economy has grown at a sustained pace over the last few years with GDP growing at 7.5% in financial year 2005 and is likely to touch 8.1% in financial year 2006 on the back of robust growth in manufacturing & service sectors. A key beneficiary of this economic boom was the banking sector, which is witnessing credit growth of more than 30%. The incremental credit deposit ratio has climbed above 80% along with jump in deposit mobilization. Despite pressure on margins, banks have been steadily raising their net interest margins in the past few quarters through shift in asset mix, stabilization of yields on advances and cost controls. The reliance on treasury profits has gone down sharply thereby bringing in more stability to the bank’s bottomline as against earlier volatility. We expect the current growth momentum to continue with banks likely to further grow in size & profitability over the next 12-15 months.
Company Snapshot - State Bank of India
Industry : Finance - Banks - Public Sector
Company Profile
we are very much bullish on sbi we think it will be a new record setter of the market one can buy with a trg of 1350 tahn 1500.

utv softwear and reliance engery both loking good at charts one can buy both of these two scripts with a 10% gain on short period tulip IT is also giving good returns in 15 days one can book profit in tulip it and one can also exit in rnrl when it crosses 30 now adays market is choopy not showing any upword movements one can book profits and stay with cash the hot stocks of this weeks are sesgoa patni comp saytam comp and jp associates.

TCS would report a double-digit growth in topline. But we would like to be a little more conservative; our estimates are around 9% for the topline growth, margins maybe slightly impacted because of rupee strengthening but they could still report profit growth on a sequential basis of around 7-8%. So a good growth is expected and it is likely to be a dark horse. One can look to take a short-term bet in terms of result expectations.” Analysts expect TCS to report 6.59% QoQ growth in Q3FY07, driven by high volume growth. Ramp-ups in large deals are also expected to add to revenue growth.